Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Instruments
    • 2.1.1.1. Secondary Instrument
    • 2.1.1.2. Primary Instrument
  • 2.1.2. Research Approaches
    • 2.1.2.1. Bottom-up Approach
    • 2.1.2.2. Top-down Approach
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
  • 2.1.5. Vendor Inclusion Criteria
• 2.2. Forecasting Methodology
  • 2.2.1. Methodology for Market Estimation & Forecasting
  • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight

• 4.1. Market Connectivity
• 4.2. Market Data Feed
• 4.3. Market Vendor Ranking Analysis
• 4.4. Market Dynamics
  • 4.4.1. Drivers
  • 4.4.2. Restraints
  • 4.4.3. Opportunities
  • 4.4.4. Challenges
• 4.5. Porter’s Five Forces Analysis
  • 4.5.1. Threat of New Entrants
  • 4.5.2. Threat of Substitutes
  • 4.5.3. Bargaining Power of Customers
  • 4.5.4. Bargaining Power of Suppliers
  • 4.5.5. Industry Rivalry

5. Global Rheumatology Therapeutics Market, by Indication

• 5.1. Introduction
• 5.2. Ankylosing Spondylitis
• 5.3. Gout
• 5.4. Osteoarthritis
• 5.5. Psoriatic Arthritis
• 5.6. Rheumatoid Arthritis

6. Global Rheumatology Therapeutics Market, by Distribution Channel

• 6.1. Introduction
• 6.2. Offline Mode
• 6.3. Online Stores

7. Global Rheumatology Therapeutics Market, by Geography

• 7.1. Introduction
• 7.2. Americas Rheumatology Therapeutics Market
  • 7.2.1. Americas Rheumatology Therapeutics Market, by Country
    • 7.2.1.1. United States
    • 7.2.1.2. Brazil
    • 7.2.1.3. Canada
    • 7.2.1.4. Mexico
    • 7.2.1.5. Argentina
  • 7.2.2. Americas Rheumatology Therapeutics Market, by Indication
  • 7.2.3. Americas Rheumatology Therapeutics Market, by Distribution Channel
• 7.3. Europe, Middle East & Africa Rheumatology Therapeutics Market
  • 7.3.1. Europe, Middle East & Africa Rheumatology Therapeutics Market, by Country
    • 7.3.1.1. United Kingdom
    • 7.3.1.2. Germany
    • 7.3.1.3. France
    • 7.3.1.4. Saudi Arabia
    • 7.3.1.5. United Arab Emirates
    • 7.3.1.6. Italy
    • 7.3.1.7. Russia
  • 7.3.2. Europe, Middle East & Africa Rheumatology Therapeutics Market, by Indication
  • 7.3.3. Europe, Middle East & Africa Rheumatology Therapeutics Market, by Distribution Channel
• 7.4. Asia-Pacific Rheumatology Therapeutics Market
  • 7.4.1. Asia-Pacific Rheumatology Therapeutics Market, by Country
    • 7.4.1.1. China
    • 7.4.1.2. Japan
    • 7.4.1.3. India
    • 7.4.1.4. Australia
  • 7.4.2. Asia-Pacific Rheumatology Therapeutics Market, by Indication
  • 7.4.3. Asia-Pacific Rheumatology Therapeutics Market, by Distribution Channel

8. Competitive Strategic Window

• 8.1. Introduction
  • 8.1.1. Leverage Zone
  • 8.1.2. Vantage Zone
  • 8.1.3. Speculative Zone
  • 8.1.4. Bottleneck Zone

9. FPNV Positioning Matrix

• 9.1. Introduction
• 9.2. Scores
  • 9.2.1. Forefront
  • 9.2.2. Pathfinders
  • 9.2.3. Niche
  • 9.2.4. Vital
• 9.3. Business Strategy
• 9.4. Product Satisfaction

10. Competitive News Feed Analysis

11. Company Usability Profiles

• 11.1. AbbVie, Inc.
• 11.2. Amgen, Inc.
• 11.3. Bristol-Myers Squibb Company
• 11.4. Genentech, Inc.
• 11.5. Janssen Biotech, Inc.
• 11.6. Merck & Co., Inc.
• 11.7. Novartis AG
• 11.8. Pfizer, Inc.
• 11.9. Regeneron Pharmaceuticals, Inc.
• 11.10. Sanofi
• 11.11. Takeda Pharmaceutical
• 11.12. UCB S.A.

12. Appendix

• 12.1. Top Reports
• 12.2. Author Details

LIST OF TABLES (27 TABLES)

TABLE 1. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 2. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET RANKING, BY VENDORS, 2017

TABLE 3. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 4. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 5. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY GOUT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 6. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY OSTEOARTHRITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 7. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 8. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 9. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 10. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY OFFLINE MODE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 11. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 12. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 13. AMERICAS RHEUMATOLOGY THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 14. AMERICAS RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 15. AMERICAS RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 16. EUROPE, MIDDLE EAST & AFRICA RHEUMATOLOGY THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 17. EUROPE, MIDDLE EAST & AFRICA RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 18. EUROPE, MIDDLE EAST & AFRICA RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 19. ASIA-PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 20. ASIA-PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 21. ASIA-PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 22. 360IRESEARCH SCORES FOR FOREFRONT IN RHEUMATOLOGY THERAPEUTICS MARKET

TABLE 23. 360IRESEARCH SCORES FOR PATHFINDERS IN RHEUMATOLOGY THERAPEUTICS MARKET

TABLE 24. 360IRESEARCH SCORES FOR NICHE IN RHEUMATOLOGY THERAPEUTICS MARKET

TABLE 25. 360IRESEARCH SCORES FOR VITAL IN RHEUMATOLOGY THERAPEUTICS MARKET

TABLE 26. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR RHEUMATOLOGY THERAPEUTICS MARKET

TABLE 27. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR RHEUMATOLOGY THERAPEUTICS MARKET

LIST OF FIGURES (25 TABLES)

FIGURE 1. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: YEARS CONSIDERED FOR THE STUDY

FIGURE 2. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY RESEARCH METHODOLOGY

FIGURE 3. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY RESEARCH INSTRUMENTS

FIGURE 4. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES

FIGURE 5. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY POTENTIAL RESPONDENTS

FIGURE 6. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

FIGURE 7. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY RESEARCH APPROACHES

FIGURE 8. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY DATA TRIANGULATION

FIGURE 9. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET: KEY RESEARCH ASSUMPTIONS

FIGURE 10. RHEUMATOLOGY THERAPEUTICS MARKET: KEY MARKET CONNECTIVITY

FIGURE 11. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

FIGURE 12. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD MILLION)

FIGURE 13. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 14. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY GOUT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 15. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY OSTEOARTHRITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 16. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 17. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 18. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017 VS 2024 (USD MILLION)

FIGURE 19. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY OFFLINE MODE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 20. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 21. GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)

FIGURE 22. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY INDICATION, 2024

FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2024

FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RHEUMATOLOGY THERAPEUTICS MARKET, BY GEOGRAPHY, 2024

FIGURE 25. 360IRESEARCH FPNV POSITIONING MATRIX FOR RHEUMATOLOGY THERAPEUTICS MARKET

The global rheumatology therapeutics market is expected to grow from USD 43,941.57 million 2017 to USD 54,566.57 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 3.14%.

On the basis of indication, the global rheumatology therapeutics market is studied across Ankylosing Spondylitis, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.

On the basis of distribution channel, the global rheumatology therapeutics market is studied across Offline Mode and Online Stores.

On the basis of geography, the global rheumatology therapeutics market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

“AbbVie, Inc.: The potential growing player for the global rheumatology therapeutics market”

The key players profiled in the global rheumatology therapeutics market are AbbVie, Inc., Amgen, Inc., Bristol-Myers Squibb Company, Genentech, Inc., Janssen Biotech, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceutical, and UCB S.A..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global rheumatology therapeutics market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global rheumatology therapeutics market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global rheumatology therapeutics market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global rheumatology therapeutics market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global rheumatology therapeutics market.